Company data
Ocular Therapeutix, Inc. employees and revenue per employee
OCUL · Biotechnology · $1.65B market cap
Ocular Therapeutix, Inc. had 325 employees at the end of fiscal Dec 2025, up 18.6% from a year earlier. Revenue for the year was $51.8M, down 18.7% from a year earlier, or $159K per employee. Revenue fell while headcount grew.
Employees
325
+18.6% YoY
Revenue
$51.8M
-18.7% YoY
Revenue / employee
$159K
Peer median $459K
Rank in industry
87 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 325 | $51.8M | $159K | +18.6% | -18.7% |
| Dec 2024 | 274 | $63.7M | $233K | +2.6% | +9.0% |
| Dec 2023 | 267 | $58.4M | $219K | -2.6% | +13.5% |
| Dec 2022 | 274 | $51.5M | $188K | +20.2% | +18.3% |
| Dec 2021 | 228 | $43.5M | $191K | +26.0% | +150.1% |
| Dec 2020 | 181 | $17.4M | $96K | +12.4% | +311.7% |
| Dec 2019 | 161 | $4.2M | $26K | -3.6% | +112.4% |
| Dec 2018 | 167 | $2.0M | $12K | +40.3% | +3.5% |
| Dec 2017 | 119 | $1.9M | $16K | +0.8% | +1.9% |
| Dec 2016 | 118 | $1.9M | $16K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Ocular Therapeutix, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| FENC Fennec Pharmaceuticals Inc. | 35 | $44.6M | $1.28M | Hiring into decline |
| NKTR Nektar Therapeutics | 63 | $55.2M | $877K | Hiring into decline |
| ENTA Enanta Pharmaceuticals, Inc. | 120 | $65.3M | $544K | Contracting |
| TNGX Tango Therapeutics, Inc. | 137 | $62.4M | $455K | Leaner |
| SEPN Septerna Inc | 130 | $46.0M | $353K | Efficient growth |
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| OCUL Ocular Therapeutix, Inc. | 325 | $51.8M | $159K | Hiring into decline |
| AGIO Agios Pharmaceuticals, Inc. | 539 | $54.0M | $100K | Efficient growth |
Questions about Ocular Therapeutix, Inc.
- How many employees does Ocular Therapeutix, Inc. have?
- Ocular Therapeutix, Inc. reported 325 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 5, 2026. That is up 18.6% from a year earlier.
- What is Ocular Therapeutix, Inc.'s revenue per employee?
- Ocular Therapeutix, Inc. brought in $51.8M of revenue in fiscal Dec 2025, which is $159K per employee. That ranks 87 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare OCUL with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Ocular Therapeutix, Inc.'s annual reports (Form 10-K), latest filed February 5, 2026. This is data, not a recommendation to buy or sell OCUL.